BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 11935167)

  • 1. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
    Krulová M; Zajícová A; Fric J; Holán V
    Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism.
    Holán V; Pindjáková J; Krulová M; Neuwirth A; Fric J; Zajícová A
    Transplantation; 2006 Jun; 81(12):1708-15. PubMed ID: 16794538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
    Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
    Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of macrophages and nitric oxide in the effector phase of allotransplantation reaction.
    Holán V; Krulová M; Pindjaková J; Zajícová A
    Ann Transplant; 2001; 6(1):44-6. PubMed ID: 11803606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation.
    Hori T; Kuribayashi K; Uemoto S; Saito K; Wang L; Torii M; Shibutani S; Taniguchi K; Yagi S; Iida T; Yamamoto C; Kato T
    Transpl Immunol; 2008 Apr; 19(1):45-54. PubMed ID: 18346637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
    Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
    Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asialo GM1 positive CD8+ T cells induce skin allograft rejection in the absence of the secondary lymphoid organs.
    Yamanokuchi S; Ikai I; Nishitai R; Matsushita T; Sugimoto S; Shiotani T; Yamaoka Y
    J Surg Res; 2005 Nov; 129(1):57-63. PubMed ID: 16140338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
    Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
    Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide as a regulatory and effector molecule in the immune system.
    Holán V; Krulová M; Zajícová A; Pindjáková J
    Mol Immunol; 2002 May; 38(12-13):989-95. PubMed ID: 12009578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal rat-to-mouse xenotransplantation and the effects of anti-CD4 or anti-CD8 treatment on cytokine and nitric oxide production.
    Pindjáková J; Vítová A; Krulová M; Zajícová A; Filipec M; Holán V
    Transpl Int; 2005 Jul; 18(7):854-62. PubMed ID: 15948866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production.
    Verma ND; Boyd R; Robinson C; Plain KM; Tran GT; Hall BM
    Transplantation; 2006 Nov; 82(10):1324-33. PubMed ID: 17130782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
    Margenthaler JA; Kataoka M; Flye MW
    Transplantation; 2003 Jun; 75(12):2119-27. PubMed ID: 12829922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.